Virtual Medicinal Product (VMP) - Agalsidase alfa 3.5mg/3.5ml solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Agalsidase alfa 3.5mg/3.5ml solution for infusion vials Start Date 13-01-2009 End Date
Previous Name Previous Name Agalsidase alfa 3.5mg/3.5ml solution for injection vials Start Date 26-09-2005 End Date 12-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
3.5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A16AB03
BNF Start Date End Date
Current BNF 09080100 Start Date 04-04-2022 End Date
Previous BNF 09080100 Start Date 11-10-2006 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
9552311000001102 26-09-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Agalsidase alfa Based on Ingredient Substance 1 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial
4 vial
10 vial